25 XP   0   0   10

Geratherm Medical AG
Buy, Hold or Sell?

Let's analyse Geratherm together

PenkeI guess you are interested in Geratherm Medical AG. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Geratherm Medical AG. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Geratherm Medical AG

I send you an email if I find something interesting about Geratherm Medical AG.

Quick analysis of Geratherm (30 sec.)










What can you expect buying and holding a share of Geratherm? (30 sec.)

How much money do you get?

How much money do you get?
€0.52
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
€4.36
Expected worth in 1 year
€8.07
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
€4.19
Return On Investment
97.5%

For what price can you sell your share?

Current Price per Share
€4.30
Expected price per share
€3.7 - €4.98
How sure are you?
50%

1. Valuation of Geratherm (5 min.)




Live pricePrice per Share (EOD)

€4.30

Intrinsic Value Per Share

€-1.47 - €3.75

Total Value Per Share

€2.89 - €8.11

2. Growth of Geratherm (5 min.)




Is Geratherm growing?

Current yearPrevious yearGrowGrow %
How rich?$25.7m$20.2m$5.5m21.5%

How much money is Geratherm making?

Current yearPrevious yearGrowGrow %
Making money$1.1m$360.9k$749.5k67.5%
Net Profit Margin4.0%1.4%--

How much money comes from the company's main activities?

3. Financial Health of Geratherm (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#200 / 334

Most Revenue
#137 / 334

Most Profit
#94 / 334

What can you expect buying and holding a share of Geratherm? (5 min.)

Welcome investor! Geratherm's management wants to use your money to grow the business. In return you get a share of Geratherm.

What can you expect buying and holding a share of Geratherm?

First you should know what it really means to hold a share of Geratherm. And how you can make/lose money.

Speculation

The Price per Share of Geratherm is €4.3. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Geratherm.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Geratherm, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €4.36. Based on the TTM, the Book Value Change Per Share is €0.93 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.24 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.12 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Geratherm.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.204.7%0.204.7%0.020.6%0.194.3%0.276.2%
Usd Book Value Change Per Share1.0123.4%1.0123.4%-0.26-6.0%0.112.5%0.102.3%
Usd Dividend Per Share0.133.0%0.133.0%0.409.2%0.337.6%0.337.7%
Usd Total Gains Per Share1.1426.4%1.1426.4%0.143.2%0.4310.1%0.4310.0%
Usd Price Per Share5.41-5.41-9.09-9.03-9.96-
Price to Earnings Ratio26.55-26.55-372.09-112.76-76.66-
Price-to-Total Gains Ratio4.76-4.76-66.31-35.80-32.75-
Price to Book Ratio1.14-1.14-2.44-2.27-2.44-
Price-to-Total Gains Ratio4.76-4.76-66.31-35.80-32.75-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.6655
Number of shares214
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.130.33
Usd Book Value Change Per Share1.010.11
Usd Total Gains Per Share1.140.43
Gains per Quarter (214 shares)243.2692.62
Gains per Year (214 shares)973.03370.46
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
111186296328091360
222317231936560181730
3334258529098392721100
44463447388211193631470
55574308485513994531840
66685170582816795442210
77806032680119586352580
88916893777422387252950
910027755874725188163320
1011148616972027989073690

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%18.01.02.085.7%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%6.04.00.060.0%13.08.00.061.9%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%17.00.04.081.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%19.02.00.090.5%

Fundamentals of Geratherm

About Geratherm Medical AG

Geratherm Medical AG operates as a medical technology company in Germany. It operates through Healthcare Diagnostic, Respiratory, Cardio/Stroke, and Medical Warming Systems segments. The Healthcare Diagnostic segment provides clinical thermometers; and blood pressure monitors. The Respiratory segment develops and manufactures products primarily for pulmonary and cardiopulmonary function diagnostics. The Medical Warming Systems segment offers MRI-compatible incubators for premature babies under the LMT brand. The Cardio/Stroke segment offers stroke risk analysis products for the detection of atrial fibrillation. The company markets its products through pharmacies, hospitals, and clinics. It exports its products to approximately 60 countries. The company was founded in 1990 and is headquartered in Geschwenda, Germany.

Fundamental data was last updated by Penke on 2024-05-20 23:31:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of Geratherm Medical AG.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Geratherm earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Geratherm to the Medical Devices industry mean.
  • A Net Profit Margin of 4.0% means that €0.04 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Geratherm Medical AG:

  • The MRQ is 4.0%. The company is making a profit. +1
  • The TTM is 4.0%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ4.0%TTM4.0%0.0%
TTM4.0%YOY1.4%+2.6%
TTM4.0%5Y3.9%+0.0%
5Y3.9%10Y6.3%-2.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0%-10.8%+14.8%
TTM4.0%-17.8%+21.8%
YOY1.4%-13.3%+14.7%
5Y3.9%-19.6%+23.5%
10Y6.3%-24.5%+30.8%
1.1.2. Return on Assets

Shows how efficient Geratherm is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Geratherm to the Medical Devices industry mean.
  • 2.7% Return on Assets means that Geratherm generated €0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Geratherm Medical AG:

  • The MRQ is 2.7%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.7%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.7%TTM2.7%0.0%
TTM2.7%YOY1.0%+1.7%
TTM2.7%5Y2.8%-0.2%
5Y2.8%10Y4.4%-1.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7%-3.6%+6.3%
TTM2.7%-4.2%+6.9%
YOY1.0%-3.8%+4.8%
5Y2.8%-3.7%+6.5%
10Y4.4%-4.3%+8.7%
1.1.3. Return on Equity

Shows how efficient Geratherm is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Geratherm to the Medical Devices industry mean.
  • 4.6% Return on Equity means Geratherm generated €0.05 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Geratherm Medical AG:

  • The MRQ is 4.6%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 4.6%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ4.6%TTM4.6%0.0%
TTM4.6%YOY1.8%+2.8%
TTM4.6%5Y4.7%-0.1%
5Y4.7%10Y6.4%-1.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.6%-3.7%+8.3%
TTM4.6%-4.7%+9.3%
YOY1.8%-4.7%+6.5%
5Y4.7%-5.6%+10.3%
10Y6.4%-5.7%+12.1%

1.2. Operating Efficiency of Geratherm Medical AG.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Geratherm is operating .

  • Measures how much profit Geratherm makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Geratherm to the Medical Devices industry mean.
  • An Operating Margin of 5.4% means the company generated €0.05  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Geratherm Medical AG:

  • The MRQ is 5.4%. The company is operating less efficient.
  • The TTM is 5.4%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ5.4%TTM5.4%0.0%
TTM5.4%YOY2.4%+3.0%
TTM5.4%5Y7.0%-1.6%
5Y7.0%10Y10.0%-3.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ5.4%-28.6%+34.0%
TTM5.4%-13.8%+19.2%
YOY2.4%-14.5%+16.9%
5Y7.0%-18.9%+25.9%
10Y10.0%-24.4%+34.4%
1.2.2. Operating Ratio

Measures how efficient Geratherm is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.95 means that the operating costs are €0.95 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Geratherm Medical AG:

  • The MRQ is 0.946. The company is less efficient in keeping operating costs low.
  • The TTM is 0.946. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.946TTM0.9460.000
TTM0.946YOY0.965-0.019
TTM0.9465Y0.927+0.019
5Y0.92710Y0.917+0.010
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9461.424-0.478
TTM0.9461.431-0.485
YOY0.9651.396-0.431
5Y0.9271.413-0.486
10Y0.9171.375-0.458

1.3. Liquidity of Geratherm Medical AG.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Geratherm is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 6.57 means the company has €6.57 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Geratherm Medical AG:

  • The MRQ is 6.574. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.574. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.574TTM6.5740.000
TTM6.574YOY2.327+4.247
TTM6.5745Y3.621+2.953
5Y3.62110Y4.329-0.709
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ6.5742.689+3.885
TTM6.5742.724+3.850
YOY2.3273.418-1.091
5Y3.6213.658-0.037
10Y4.3293.632+0.697
1.3.2. Quick Ratio

Measures if Geratherm is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Geratherm to the Medical Devices industry mean.
  • A Quick Ratio of 4.51 means the company can pay off €4.51 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Geratherm Medical AG:

  • The MRQ is 4.515. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.515. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.515TTM4.5150.000
TTM4.515YOY1.801+2.714
TTM4.5155Y2.760+1.755
5Y2.76010Y3.594-0.834
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.5151.494+3.021
TTM4.5151.532+2.983
YOY1.8012.100-0.299
5Y2.7602.336+0.424
10Y3.5942.596+0.998

1.4. Solvency of Geratherm Medical AG.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Geratherm assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Geratherm to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.38 means that Geratherm assets are financed with 38.1% credit (debt) and the remaining percentage (100% - 38.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Geratherm Medical AG:

  • The MRQ is 0.381. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.381. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.381TTM0.3810.000
TTM0.381YOY0.461-0.080
TTM0.3815Y0.405-0.024
5Y0.40510Y0.343+0.063
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3810.417-0.036
TTM0.3810.401-0.020
YOY0.4610.335+0.126
5Y0.4050.441-0.036
10Y0.3430.454-0.111
1.4.2. Debt to Equity Ratio

Measures if Geratherm is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Geratherm to the Medical Devices industry mean.
  • A Debt to Equity ratio of 65.5% means that company has €0.66 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Geratherm Medical AG:

  • The MRQ is 0.655. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.655. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.655TTM0.6550.000
TTM0.655YOY0.860-0.205
TTM0.6555Y0.694-0.039
5Y0.69410Y0.537+0.157
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6550.601+0.054
TTM0.6550.607+0.048
YOY0.8600.487+0.373
5Y0.6940.640+0.054
10Y0.5370.682-0.145

2. Market Valuation of Geratherm Medical AG

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Geratherm generates.

  • Above 15 is considered overpriced but always compare Geratherm to the Medical Devices industry mean.
  • A PE ratio of 26.55 means the investor is paying €26.55 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Geratherm Medical AG:

  • The EOD is 22.877. Based on the earnings, the company is fair priced.
  • The MRQ is 26.548. Based on the earnings, the company is overpriced. -1
  • The TTM is 26.548. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD22.877MRQ26.548-3.671
MRQ26.548TTM26.5480.000
TTM26.548YOY372.086-345.538
TTM26.5485Y112.765-86.217
5Y112.76510Y76.661+36.104
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD22.877-1.080+23.957
MRQ26.548-1.704+28.252
TTM26.548-2.344+28.892
YOY372.086-2.965+375.051
5Y112.765-2.436+115.201
10Y76.661-2.057+78.718
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Geratherm Medical AG:

  • The EOD is 36.413. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 42.256. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 42.256. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD36.413MRQ42.256-5.843
MRQ42.256TTM42.2560.000
TTM42.256YOY-128.844+171.100
TTM42.2565Y-15.964+58.220
5Y-15.96410Y-12.149-3.815
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD36.413-2.023+38.436
MRQ42.256-3.111+45.367
TTM42.256-3.078+45.334
YOY-128.844-5.861-122.983
5Y-15.964-5.350-10.614
10Y-12.149-5.716-6.433
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Geratherm is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 1.14 means the investor is paying €1.14 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Geratherm Medical AG:

  • The EOD is 0.986. Based on the equity, the company is cheap. +2
  • The MRQ is 1.144. Based on the equity, the company is underpriced. +1
  • The TTM is 1.144. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.986MRQ1.144-0.158
MRQ1.144TTM1.1440.000
TTM1.144YOY2.441-1.297
TTM1.1445Y2.269-1.125
5Y2.26910Y2.441-0.172
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.9862.052-1.066
MRQ1.1442.362-1.218
TTM1.1442.532-1.388
YOY2.4412.943-0.502
5Y2.2694.053-1.784
10Y2.4414.527-2.086
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Geratherm Medical AG compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.9280.9280%-0.238+126%0.098+850%0.093+898%
Book Value Per Share--4.3614.3610%3.433+27%3.741+17%3.786+15%
Current Ratio--6.5746.5740%2.327+183%3.621+82%4.329+52%
Debt To Asset Ratio--0.3810.3810%0.461-17%0.405-6%0.343+11%
Debt To Equity Ratio--0.6550.6550%0.860-24%0.694-6%0.537+22%
Dividend Per Share--0.1200.1200%0.365-67%0.301-60%0.305-61%
Eps--0.1880.1880%0.023+735%0.172+9%0.245-23%
Free Cash Flow Per Share--0.1180.1180%-0.065+155%-0.140+218%0.042+183%
Free Cash Flow To Equity Per Share--0.9170.9170%-0.715+178%-0.098+111%-0.084+109%
Gross Profit Margin---0.651-0.6510%-3.290+405%-1.852+184%-1.117+72%
Intrinsic Value_10Y_max--3.748--------
Intrinsic Value_10Y_min---1.468--------
Intrinsic Value_1Y_max--0.150--------
Intrinsic Value_1Y_min---0.143--------
Intrinsic Value_3Y_max--0.622--------
Intrinsic Value_3Y_min---0.436--------
Intrinsic Value_5Y_max--1.302--------
Intrinsic Value_5Y_min---0.733--------
Market Cap23337992.000-16%27170550.00027170550.0000%45481947.200-40%45195535.440-40%49834289.872-45%
Net Profit Margin--0.0400.0400%0.014+193%0.039+1%0.063-37%
Operating Margin--0.0540.0540%0.024+124%0.070-23%0.100-46%
Operating Ratio--0.9460.9460%0.965-2%0.927+2%0.917+3%
Pb Ratio0.986-16%1.1441.1440%2.441-53%2.269-50%2.441-53%
Pe Ratio22.877-16%26.54826.5480%372.086-93%112.765-76%76.661-65%
Price Per Share4.300-16%4.9904.9900%8.380-40%8.324-40%9.180-46%
Price To Free Cash Flow Ratio36.413-16%42.25642.2560%-128.844+405%-15.964+138%-12.149+129%
Price To Total Gains Ratio4.104-16%4.7634.7630%66.310-93%35.800-87%32.754-85%
Quick Ratio--4.5154.5150%1.801+151%2.760+64%3.594+26%
Return On Assets--0.0270.0270%0.010+177%0.028-6%0.044-39%
Return On Equity--0.0460.0460%0.018+155%0.047-3%0.064-28%
Total Gains Per Share--1.0481.0480%0.126+729%0.399+163%0.398+163%
Usd Book Value--25761357.89525761357.8950%20215021.260+27%22049030.395+17%22301627.726+16%
Usd Book Value Change Per Share--1.0071.0070%-0.259+126%0.106+850%0.101+898%
Usd Book Value Per Share--4.7314.7310%3.725+27%4.059+17%4.108+15%
Usd Dividend Per Share--0.1300.1300%0.396-67%0.327-60%0.331-61%
Usd Eps--0.2040.2040%0.024+735%0.186+9%0.266-23%
Usd Free Cash Flow--697655.000697655.0000%-383005.000+155%-821779.000+218%245861.000+184%
Usd Free Cash Flow Per Share--0.1280.1280%-0.071+155%-0.151+218%0.045+183%
Usd Free Cash Flow To Equity Per Share--0.9950.9950%-0.775+178%-0.106+111%-0.091+109%
Usd Market Cap25321721.320-16%29480046.75029480046.7500%49347912.712-40%49037155.952-40%54070204.511-45%
Usd Price Per Share4.666-16%5.4145.4140%9.092-40%9.032-40%9.961-46%
Usd Profit--1110438.9101110438.9100%360921.995+208%1051337.441+6%1462457.395-24%
Usd Revenue--28047921.61528047921.6150%26732960.205+5%25894310.106+8%23750613.761+18%
Usd Total Gains Per Share--1.1371.1370%0.137+729%0.433+163%0.432+163%
 EOD+4 -4MRQTTM+0 -0YOY+29 -75Y+25 -1110Y+19 -17

3.2. Fundamental Score

Let's check the fundamental score of Geratherm Medical AG based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1522.877
Price to Book Ratio (EOD)Between0-10.986
Net Profit Margin (MRQ)Greater than00.040
Operating Margin (MRQ)Greater than00.054
Quick Ratio (MRQ)Greater than14.515
Current Ratio (MRQ)Greater than16.574
Debt to Asset Ratio (MRQ)Less than10.381
Debt to Equity Ratio (MRQ)Less than10.655
Return on Equity (MRQ)Greater than0.150.046
Return on Assets (MRQ)Greater than0.050.027
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Geratherm Medical AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.535
Ma 20Greater thanMa 504.382
Ma 50Greater thanMa 1004.375
Ma 100Greater thanMa 2004.916
OpenGreater thanClose4.200
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Long-term Assets Other  3,6971,8345,531-65,525-1,2204,305-19,038-14,733
Total Other Income Expense Net -430419-11-308-32038-282609327



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets38,380
Total Liabilities14,637
Total Stockholder Equity22,336
 As reported
Total Liabilities 14,637
Total Stockholder Equity+ 22,336
Total Assets = 38,380

Assets

Total Assets38,380
Total Current Assets23,317
Long-term Assets15,064
Total Current Assets
Cash And Cash Equivalents 8,737
Short-term Investments 2,149
Net Receivables 2,979
Inventory 7,742
Other Current Assets 1,710
Total Current Assets  (as reported)23,317
Total Current Assets  (calculated)23,317
+/-0
Long-term Assets
Property Plant Equipment 9,985
Goodwill 79
Intangible Assets 4,217
Other Assets 0
Long-term Assets  (as reported)15,064
Long-term Assets  (calculated)14,281
+/- 783

Liabilities & Shareholders' Equity

Total Current Liabilities3,547
Long-term Liabilities11,090
Total Stockholder Equity22,336
Total Current Liabilities
Short-term Debt 3,474
Accounts payable 1,513
Other Current Liabilities 2,034
Total Current Liabilities  (as reported)3,547
Total Current Liabilities  (calculated)7,021
+/- 3,474
Long-term Liabilities
Long term Debt 9,295
Capital Lease Obligations Min Short Term Debt-3,474
Other Liabilities 2,435
Long-term Liabilities Other 2,034
Long-term Liabilities  (as reported)11,090
Long-term Liabilities  (calculated)10,290
+/- 800
Total Stockholder Equity
Common Stock5,445
Retained Earnings -664
Accumulated Other Comprehensive Income -69
Other Stockholders Equity 17,624
Total Stockholder Equity (as reported)22,336
Total Stockholder Equity (calculated)22,336
+/-0
Other
Capital Stock5,445
Cash and Short Term Investments 10,886
Common Stock Shares Outstanding 5,445
Current Deferred Revenue-3,474
Liabilities and Stockholders Equity 38,380
Net Debt 557
Net Invested Capital 31,630
Net Working Capital 21,368
Property Plant and Equipment Gross 9,985
Short Long Term Debt Total 9,295



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-31
> Total Assets 
18,899
19,140
18,874
18,554
19,020
18,166
15,060
22,652
29,961
24,583
27,385
28,697
28,489
30,248
28,403
28,467
29,380
33,264
35,990
34,560
38,380
38,38034,56035,99033,26429,38028,46728,40330,24828,48928,69727,38524,58329,96122,65215,06018,16619,02018,55418,87419,14018,899
   > Total Current Assets 
11,828
12,122
12,075
13,282
13,856
13,012
9,588
16,670
20,885
18,840
21,810
23,538
23,562
25,389
23,654
22,944
18,847
20,788
21,399
19,612
23,317
23,31719,61221,39920,78818,84722,94423,65425,38923,56223,53821,81018,84020,88516,6709,58813,01213,85613,28212,07512,12211,828
       Cash And Cash Equivalents 
8,162
8,704
8,349
5,965
5,130
2,085
1,373
5,703
5,519
4,224
8,810
11,112
8,869
9,683
9,518
8,811
5,361
4,139
4,855
2,264
8,737
8,7372,2644,8554,1395,3618,8119,5189,6838,86911,1128,8104,2245,5195,7031,3732,0855,1305,9658,3498,7048,162
       Short-term Investments 
0
0
0
0
0
0
2,991
5,355
6,502
5,309
3,718
4,346
4,203
5,016
2,530
4,025
2,462
5,404
5,407
4,206
2,149
2,1494,2065,4075,4042,4624,0252,5305,0164,2034,3463,7185,3096,5025,3552,991000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
3,248
3,197
3,125
3,450
3,056
2,639
3,317
3,717
4,502
2,979
2,9794,5023,7173,3172,6393,0563,4503,1253,1973,24800000000000
       Inventory 
2,137
1,828
2,205
2,296
2,572
2,932
5,059
2,823
4,799
5,963
5,460
4,536
7,031
6,816
7,760
6,788
7,298
7,865
7,305
8,540
7,742
7,7428,5407,3057,8657,2986,7887,7606,8167,0314,5365,4605,9634,7992,8235,0592,9322,5722,2962,2051,8282,137
       Other Current Assets 
1,530
1,590
1,521
5,020
6,155
7,995
164
2,789
4,064
3,343
3,822
3,544
3,459
3,875
3,846
3,320
3,728
64
114
100
1,710
1,710100114643,7283,3203,8463,8753,4593,5443,8223,3434,0642,7891647,9956,1555,0201,5211,5901,530
   > Long-term Assets 
7,071
7,017
6,799
5,272
5,164
5,154
5,472
5,982
9,076
5,743
5,575
5,159
4,927
4,859
4,749
5,523
10,533
12,476
14,592
14,949
15,064
15,06414,94914,59212,47610,5335,5234,7494,8594,9275,1595,5755,7439,0765,9825,4725,1545,1645,2726,7997,0177,071
       Property Plant Equipment 
2,575
2,248
2,050
1,841
2,244
2,244
1,764
2,319
3,202
3,711
3,762
3,333
3,337
3,723
3,577
3,895
7,633
8,629
9,678
9,322
9,985
9,9859,3229,6788,6297,6333,8953,5773,7233,3373,3333,7623,7113,2022,3191,7642,2442,2441,8412,0502,2482,575
       Goodwill 
0
85
76
76
0
0
0
0
76
76
76
76
76
76
76
76
76
0
0
90
79
79900076767676767676767600007676850
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
50
15
270
270
426
1,420
0
0
0
0
00001,420426270270155000000000000
       Intangible Assets 
420
418
345
392
0
0
0
0
707
453
456
617
646
528
550
582
827
2,197
3,079
4,067
4,217
4,2174,0673,0792,1978275825505286466174564537070000392345418420
       Long-term Assets Other 
1,336
1,347
1,347
0
2,453
2,239
0
0
3,000
0
50
50
284
5,139
2,805
605
3,697
5,531
5,525
4,305
-14,733
-14,7334,3055,5255,5313,6976052,8055,139284505003,000002,2392,45301,3471,3471,336
> Total Liabilities 
3,211
2,668
2,101
1,431
1,572
1,912
2,413
4,982
9,445
5,918
8,764
8,617
8,146
8,309
7,846
7,450
9,253
14,084
16,065
15,929
14,637
14,63715,92916,06514,0849,2537,4507,8468,3098,1468,6178,7645,9189,4454,9822,4131,9121,5721,4312,1012,6683,211
   > Total Current Liabilities 
1,233
1,004
1,405
749
0
0
1,492
1,909
3,694
3,426
3,673
4,388
4,730
5,510
5,324
3,961
5,372
7,024
7,827
8,428
3,547
3,5478,4287,8277,0245,3723,9615,3245,5104,7304,3883,6733,4263,6941,9091,492007491,4051,0041,233
       Short-term Debt 
269
191
660
0
0
0
670
441
241
1,505
1,664
2,143
2,109
1,145
1,375
344
1,099
2,348
3,452
3,123
3,474
3,4743,1233,4522,3481,0993441,3751,1452,1092,1431,6641,505241441670000660191269
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
5,674
2,109
1,145
1,375
344
1,099
2,058
3,200
2,845
0
02,8453,2002,0581,0993441,3751,1452,1095,67400000000000
       Accounts payable 
0
0
0
199
0
0
0
708
1,127
1,131
1,171
1,358
998
1,707
1,783
996
1,608
1,411
1,503
1,430
1,513
1,5131,4301,5031,4111,6089961,7831,7079981,3581,1711,1311,127708000199000
       Other Current Liabilities 
963
812
745
550
0
0
822
759
2,326
789
837
887
1,623
2,658
2,166
2,621
2,046
1,436
1,368
1,538
2,034
2,0341,5381,3681,4362,0462,6212,1662,6581,6238878377892,32675982200550745812963
   > Long-term Liabilities 
1,978
1,664
696
683
0
0
922
3,073
5,751
2,492
5,091
4,229
3,416
2,799
2,522
3,488
3,880
7,060
8,238
7,501
11,090
11,0907,5018,2387,0603,8803,4882,5222,7993,4164,2295,0912,4925,7513,073922006836961,6641,978
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,534
1,052
2,635
2,279
5,271
6,526
5,738
0
05,7386,5265,2712,2792,6351,0521,5340000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
698
586
474
749
512
1,299
1,379
1,287
1,763
2,435
2,4351,7631,2871,3791,29951274947458669800000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
160
157
161
304
463
1,337
1,952
2,783
2,994
0
02,9942,7831,9521,33746330416115716000000000000
> Total Stockholder Equity
15,672
16,469
16,711
17,060
17,448
16,254
12,595
17,667
20,617
19,058
19,034
20,705
20,709
22,508
21,261
21,019
20,320
19,827
20,302
18,522
22,336
22,33618,52220,30219,82720,32021,01921,26122,50820,70920,70519,03419,05820,61717,66712,59516,25417,44817,06016,71116,46915,672
   Common Stock
4,461
4,490
4,500
4,500
0
0
4,500
4,500
4,950
4,950
4,950
4,950
4,950
4,950
4,950
4,950
4,950
4,950
4,950
4,950
5,445
5,4454,9504,9504,9504,9504,9504,9504,9504,9504,9504,9504,9504,9504,5004,500004,5004,5004,4904,461
   Retained Earnings Total Equity000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
-4,801
0
-5,450
-5,946
-6,541
-7,118
-7,768
-8,591
-9,555
-9,929
2,243
1,909
2,004
-69
-692,0041,9092,243-9,929-9,555-8,591-7,768-7,118-6,541-5,946-5,4500-4,8010000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
11,035
11,035
12,174
12,174
12,174
12,174
12,203
0
012,20312,17412,17412,17412,17411,03511,0350000000000000
   Treasury Stock000000000000000000000
   Other Stockholders Equity 
11,211
11,980
12,211
12,560
0
0
8,095
17,969
15,667
19,558
20,030
22,295
22,877
25,326
24,902
25,624
25,298
12,174
12,174
12,203
17,624
17,62412,20312,17412,17425,29825,62424,90225,32622,87722,29520,03019,55815,66717,9698,0950012,56012,21111,98011,211



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.